Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
Pharmacovigilance Pharmacovigilance
Pharmacovigilance and BA/BE Studies, Central Laboratory...
Upcoming
BA/BE Studies BA/BE Studies
BA/BE Studies and Pharmacovigilance, Central Laboratory...
Upcoming
Central Laboratory Services Central Laboratory Services
Central Laboratory Services and Pharmacovigilance, BA/BE Studies,...
Upcoming
Clinical Data Management Clinical Data Management
Clinical Data Management and Pharmacovigilance, BA/BE Studies,
Upcoming
Medical Writing Medical Writing
Medical Writing and Pharmacovigilance, BA/BE Studies,
Upcoming
Pharmaceutical Excipients Pharmaceutical Excipients
Pharmaceutical Excipients and its peer markets - Digital Pathology,
Upcoming
Enzyme Immunoassays (EIA) Enzyme Immunoassays (EIA)
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas enzyme immunoassays market. Germany commanded the largest share of the European enzyme immunoassays market. Japan commanded the largest share of the Asia-Pacific enzyme immunoassays market. The report “Global Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.  
Upcoming
Fluorescence Immunoassays (FIA) Fluorescence Immunoassays (FIA)
Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. FIA gives the same sensitivity as radioimmunoassay (RIA) and enzyme immunoassays (EIA), but at lower costs because the fluorescent dyes are available at lower prices when compared to enzymes and radioisotopes. The report “Global Fluorescence immunoassays (FIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.
Upcoming
Chemiluminescence Immunoassays (CLIA) Chemiluminescence Immunoassays (CLIA)
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas Chemiluminescence immunoassays (CLIA) market, Germany commanded the largest share of the European Chemiluminescence immunoassays (CLIA) market, Japan commanded the largest share of the Asia-Pacific Chemiluminescence immunoassays (CLIA) market. The report “Global Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.
Upcoming
Radioimmunoassays (RIA) Radioimmunoassays (RIA)
Radioimmunoassay accounted for about one-fifth of the share of the overall immunoassays market in 2013. The report “Global Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.
Upcoming
Mechanical Mechanical
Mechanical and Immunologic, Chemical (Chromogenic) Assays...
Upcoming
Immunologic Immunologic
Immunologic and Mechanical, Chemical (Chromogenic) Assays...
Upcoming
Chemical (Chromogenic) Assays Chemical (Chromogenic) Assays
Chemical (Chromogenic) Assays and Mechanical, Immunologic and
Upcoming
Molecular PCR Testing Molecular PCR Testing
Molecular PCR Testing and Mechanical, Immunologic and
Upcoming
Titanium Implants  Titanium Implants 
Titanium Implants  and Zirconium Implants  adds up to total
Upcoming
Diagnostic Ultrasound   Diagnostic Ultrasound  
Diagnostic Ultrasound   and Therapeutic Ultrasound adds up to total
Upcoming
Therapeutic Ultrasound Therapeutic Ultrasound
Therapeutic Ultrasound and Diagnostic Ultrasound   adds up to total
Upcoming
Hemodialysis Hemodialysis
The “Global Hemodialysis Market”, mainly driven by increase in the number of ESRD patient population, was pegged at $ 49.3 billion in 2012 and expected to be $ 78.2 billion by 2020, growing at a CAGR of 5.9%. Hemodialysis has 3 main segments such as Hemodialysis machines, Hemodialysis consumables and Hemodialysis services. The key players are Honeywell (U.S.), Carematix (U.S.), Philips (The Netherlands), Bosch (U.S.), Telcomed (Ireland), Intel (U.S.), Aerotel (Israel), and Tunstall (U.K.).
Upcoming
Thermal Ablation Thermal Ablation
The Global Thermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery was pegged at $9386 million in 2013 and expected to be $15480 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
Non-thermal Ablation Non-thermal Ablation
Non-thermal Ablation and Thermal Ablation adds up to total Ablation...
Upcoming
2983 reports | Show
Connect With Us
US/CAN : +1-888-502-0539